MedTrace Logo

Malignancies in Transplanted Patients

NCT02241564 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2017-10-26

No results posted yet for this study

Summary

The aim of the project is to improve the overall treatment and outcome of renal, pancreas or liver transplanted patients who have encountered a malignancy by a structured treatment program for diagnosis and treatment of the malignancy, optimization of the immunosuppressive treatment, follow-up and evaluation of the program.

Conditions

  • Neoplasms

Interventions

OTHER

Referral to a multidisciplinary expert panel at the Uppsala University Hospital after tumor detection

DRUG

Switch from calcineurin inhibitor to an mTOR inhibitor

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02241564 on ClinicalTrials.gov